RAGNAR CAN2002 (#1185)
Laufzeit: 01.01.2020 - 31.12.2040
imported
Kurzfassung
A phase 2 study of Erdafitinib in subjects with advanced solid tumors and FGFR gene alterations
Laufzeit: 01.01.2020 - 31.12.2040
A phase 2 study of Erdafitinib in subjects with advanced solid tumors and FGFR gene alterations